Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19-Reference-Cited by-同舟云学术

Safety and Biodistribution of Nanoligomers Targeting the SARS-CoV-2 Genome for the Treatment of COVID-19

Published:2023-02-28 Issue:3 Volume:9 Page:1656-1671
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

McCollum Colleen R.¹,Courtney Colleen M.¹²,O’Connor Nolan J.¹,Aunins Thomas R.¹,Jordan Tristan X.³,Rogers Keegan L.⁴,Brindley Stephen⁴,Brown Jared M.⁴,Nagpal Prashant²⁵^ORCID,Chatterjee Anushree¹²⁵^ORCID

Affiliation:

1. Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80303, United States

2. Sachi Bio, Colorado Technology Center, Louisville, Colorado 80027, United States

3. Department of Microbiology, New York University Langone, New York, New York 10016, United States

4. Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States

5. Antimicrobial Regeneration Consortium Labs, Louisville, Colorado 80027, United States

Funder

U.S. Department of Education

National Aeronautics and Space Administration

U.S. Department of Health and Human Services

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.2c00669

Reference77 articles.

1. A National Strategy for COVID-19 Medical Countermeasures

2. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

5. mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model;ACS Pharmacology & Translational Science;2024-08-30

2. Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids;ACS Chemical Neuroscience;2024-07-31

3. Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy;Journal of Neuroinflammation;2024-07-27

4. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model;ACS Chemical Neuroscience;2024-03-25

5. Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs;ACS Pharmacology & Translational Science;2024-03-21